DCF — PRESENCE ST. JOSEPH MEDICAL CENTER
Enterprise Value: $-560.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-560.2M
Enterprise Value
$-177.6M
PV of Cash Flows
$-382.5M
PV of Terminal Value
$-616.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $363.3M | $-34.7M | -10.0% | $-50.0M | $-45.5M |
| Year 2 | $374.1M | $-32.0M | -9.0% | $-47.8M | $-39.5M |
| Year 3 | $385.4M | $-29.1M | -8.0% | $-45.4M | $-34.1M |
| Year 4 | $396.9M | $-28.0M | -7.0% | $-44.8M | $-30.6M |
| Year 5 | $408.8M | $-27.8M | -7.0% | $-45.1M | $-28.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-560.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$352.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10042286254395943
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5